Impact of Comorbidities on Treatments and Outcomes of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension.

Can Respir J · 2025 · PMC12602041 · PMID 41220703

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

did not reach statistical significancep < 0.08so close (0.05 < p ≤ 0.1)

In multivariate survival analysis, high comorbidity was associated with poorer prognosis, but this did not reach statistical significance (HR 1.44, 95% CI 0.95 to 2.16, p < 0.08).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.